| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872181 | The Annals of Thoracic Surgery | 2015 | 8 Pages |
Abstract
Overexpression of HSF1 is common and significantly correlated with tumor angiogenesis in NSCLC. Patients with high HSF1 expression had poorer overall, disease-free, and disease-specific survival. These current findings suggest that HSF1 may serve as a novel prognostic marker and potential therapeutic target molecule for antiangiogenic therapy in patients with NSCLC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jingjing MD, Hui MD, Guanqing MD,